EVENTS:   The Roaring 2020s or a Rerun of the 1970s? - Edward Yardeni/Yardeni Research - 24 Mar 26   Best Equity Short Ideas Conference Call 13 - Thomas Chanos/Badger Consultants & Dr. Aaron Fletcher/Bios Research & Jonathan Telgener/Channel Dynamics & Ed Steele/Iron Blue Financials & John Zolidis/Quo Vadis Capital & Mark Hiley/The Analyst - 26 Mar 26     ROADSHOWS: Chinese Equity Ideas & Channel Checks Across 50 sub-sectors - Don Ma /Horizon Insights   •   London   23 - 27 Mar 26       Long Short European Equity Research - Harry Grist /The Analyst   •   New York   26 Mar 26       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   27 - 27 Mar 26      
Filters

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

AI driven 10Q / 10K text analysis

280First

Since there are always reasons when companies change the wording in their financial filings, being alerted to these changes allows investors to realise potential risk factors and opportunities before they are reflected in the market. Recent alerts include: 1) AvalonBay Communities - bylaws last amended in Oct 23; is the added wording to its 2025 10K, prompted by takeover interest? 2) Diamondback Energy - loss of customers; Endeavor equityholders planning on selling shares? 3) GoDaddy - Microsoft partnership in trouble? 4) Align - more benign competitive environment. Caution on OSOs, DSOs and other large group practices. 5) Armstrong World Industries - better demand expectations. 6) Cigna - clients terminating / modifying contract terms?

Edition: 231

- 06 March, 2026


Special Sits Idea Forum

MYST Advisors

MYST’s buyside events continue to draw impressive attendance while consistently delivering strong results. This Forum was notable for highlighting several foreign companies with imminent US listings (Ashtead, Guardian Metal Resources, SK Square) as well as Healthcare stocks (Cigna, Qiagen). Other ideas presented include:

Boise Cascade (BCC) - trough multiple at cycle bottom with potential business split under new CEO. TP $207 (145% upside).
Core Scientific (CORZ) - robust HPC pipeline not reflected despite buildout running ahead of schedule. TP $34 (95% upside).
Ralliant (RAL) - cyclical inflection masked by “one-time” cost headwinds. TP $60 (35% upside).
VSE (VSEC) - compelling entry point for “transformational” aerospace story. TP $300 (35% upside).

Edition: 230

- 20 February, 2026


The ways to use FCF yield to pick stocks

Trivariate Research

Trivariate Research's latest report analyses FCF trends of US corporates, both yield and conversion, efficacy of the signal and opportunities that may surface when financial conditions tighten. Key findings include: 1) FCF yield works in SMID cap and middle quality best. 2) From a sector perspective, it is effective in Machinery; volatile in Healthcare. 3) FCF yield matters more when financial conditions are loose. As soon as it begins tightening, de-emphasizing FCF yield and focusing on FCF conversion to pick winners from losers in “junk stocks” is prudent. 4) Quantitatively derived longs include Cigna, Cummins and Centene. Shorts include Elevance Health, Humana and Xylem.

Edition: 187

- 31 May, 2024